知搜-全球专利检索

  1. Login
  2. Sign Up

Search Results

10 records (took 0.012 seconds)

    Oral microbiota composition for oral and/or sinus infections
    2.
    发明授权
    Oral microbiota composition for oral and/or sinus infections 有权

    公开(公告)号：US11083760B2

    公开(公告)日：2021-08-10

    申请号：US16519909

    申请日：2019-07-23

    Applicant: Knoze Jr. Corporation

    Inventor： Shunsheng Han

    IPC: A61K35/744 ,  A61K47/36 ,  A61K9/00 ,  A61K31/198

    Abstract: A formulated oral prebiotic edible composition useful for promoting a desired oral microbiota to treat a respiratory allergic condition and/or an oral and/or sinus infection condition in a subject in need of such treatment, the oral prebiotic including comprising L-arginine, the L-arginine including free individual molecules of L-arginine, the free individual molecules of L-arginine L present at a concentration of greater than about 0.1 wt %; a carrier, and a sugar comprising at least one of a monosaccharide and disaccharide; the composition in a configuration suitable to be maintained including being substantially dissolved within the oral cavity for over a period of at least about 1 minute to about an hour, the composition in an effective amount to thereby selectively promote an increased concentration of oral microbiota to thereby treat the respiratory and/or oral and/or sinus related allergy condition, the selected oral microbiota including Veillonella and Streptococcus.

    Oral microbiota promotion for oral and/or sinus infections
    5.
    发明授权
    Oral microbiota promotion for oral and/or sinus infections 有权

    公开(公告)号：US10398670B2

    公开(公告)日：2019-09-03

    申请号：US15706323

    申请日：2017-09-15

    Applicant: Knoze Jr. Corporation

    Inventor： Shunsheng Han

    IPC: A61K31/198 ,  A61K9/00 ,  A61K31/702 ,  A61K31/7016 ,  A61K31/719 ,  A61K31/733 ,  A61K35/644 ,  A61K36/736 ,  A61K36/54 ,  A61K36/898 ,  A23L33/135 ,  B08B3/10 ,  A61K36/185 ,  A61P31/00

    Abstract: A method of promoting a desired oral microbiota to treat an oral and/or sinus infection condition in a subject in need of such treatment including providing a preformulated prebiotic edible composition including an amino acid containing ingredient comprising individual molecules of L-arginine; substantially removing a biofilm from surfaces within an oral cavity by heating the inside of the oral cavity to a temperature of about 100 deg F. to about 130 deg F.; wherein following removal of the biofilm, the composition is provided contained and at least partially dissolved within an oral cavity of the subject for a period of at least from about 30 seconds to about an hour on a daily basis of at least two consecutive days to promote an increased concentration of selected oral microbiota, the selected microbiota comprising Veillonella and Streptococcus, thereby treating the oral and/or sinus infection condition.

    Oral microbiota transformation for the relief of immune system associated inflammations
    7.
    发明授权
    Oral microbiota transformation for the relief of immune system associated inflammations 有权

    公开(公告)号：US11083759B2

    公开(公告)日：2021-08-10

    申请号：US16505341

    申请日：2019-07-08

    Applicant: Knoze Jr. Corporation

    Inventor： Shunsheng Han

    IPC: A61K35/744 ,  A61K31/198 ,  A61K9/00 ,  A61K47/36 ,  A61K47/26

    Abstract: A method of selectively promoting a desired oral microbiota to treat an inflammation condition associated with an allergic reaction in a subject in need of such treatment including providing a composition including: at least one live bacterial population including lactic acid producing bacteria and lactic acid fermenting bacteria; and, an amino acid containing ingredient comprising L-arginine; at least partially removing a biofilm within an oral cavity of the subject; wherein the composition is contained within the oral cavity of the subject in an effective amount to selectively promote an increased concentration of selected oral microbiota comprising the lactic acid producing bacteria and the lactic acid fermenting bacteria to thereby treat the inflammation condition.

Patent Agency Ranking